| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | An indole alkaloid fundamental parent with a structure of 9H-beta-carboline carrying a methyl substituent at C-1. It has been isolated from the bark of Sickingia rubra, Symplocus racemosa, Passiflora incarnata, Peganum harmala, Banisteriopsis caapi and Tribulus terrestris, as well as from tobacco smoke. It is a specific, reversible inhibitor of monoamine oxidase A. (Chemical Entities of Biological Interest Ontology, CHEBI_5623) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=HARMAN |
| Similar Terms | |
| Downloads & Tools |
6 interacting proteins for the HARMAN drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| RAD54L | RAD54-like (S. cerevisiae) | 0.17644 |
| ATAD5 | ATPase family, AAA domain containing 5 | 0.0299051 |
| HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 | 0.0212578 |
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.0151062 |
| CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 0.0144386 |
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.00995711 |